MedPath

Phase III clinical trial to evaluate the diagnostic accuracy of QFR

Phase 3
Conditions
Stable angina or stenosis after AMI
Registration Number
JPRN-jRCT2032210032
Lead Sponsor
van Schaik-Yamamoto Yuko
Brief Summary

QFR showed high diagnostic accuracy in comparison with FFR as gold standard of functional assessment of coronary arteries.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
186
Inclusion Criteria

Patients with stable angina or patients who undergo a secondary assessment of stenosis after AMI - 20 years of age or older
- Patients who can give written consent to the participation

Exclusion Criteria

- Patients who had myocardial infarction within 72 hours
- Patients with severe asthma or severe chronic obstructive pulmonary disease
- Patients with severe heart failure

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the diagnostic accuracy of QFR with FFR as gold standard, and compare the diagnostic accuracy of QFR with that of anatomical assessment by QCA.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath